Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping
Launched by STANFORD UNIVERSITY · Apr 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Huntington's Disease Biobank, is looking for new ways to track the onset and progression of Huntington's disease, which is a genetic condition that affects movement and cognitive function. Researchers plan to use advanced technology, like video recordings and a mobile app, to monitor patients' movements from home. By analyzing these videos with machine learning, they hope to create specific markers that can help identify changes in symptoms over time, similar to what an expert neurologist would do in a clinic.
To participate, individuals must have tested positive for the Huntington’s disease mutation. The study will require one in-person visit each year and a short remote visit every three months to record movement videos via Zoom or Facetime. Participants will also receive modern wristbands and the mobile app to help with monitoring. This research aims to improve understanding and treatment of Huntington's disease, making it an important opportunity for those eligible to contribute to advancements in care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with a positive test for the HD expansion mutation.
- Exclusion Criteria:
- • Individuals with movement disorders with a negative test for the HD expansion mutation.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Kyan Younes, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported